Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    www.tecan.com
    3 April 2025

    Tecan expands portfolio for specialty diagnostics with an asset purchase relating to certain ELISA kits

    Männedorf, Switzerland, April 3, 2025 – Tecan Group (SIX Swiss Exchange: TECN), announces an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity Inc. The ...

    OBN logo
    3 April 2025

    BioTrinity 2025: Over 800 professionals convene to paint a picture of hope for UK life sciences

    BioTrinity 2025 welcomed over 800 delegates, matching the highest-ever attendance set in 2024.Three action-packed tracks covered investment trends, regulatory shifts, and cutting-edge scientific advancements.Nearly 10,000 meetings requested, with 2,000 in-person, fuelling partnerships a...

    Andrw Wilkes CEO of S&W
    2 April 2025

    S&W launches as a leader in the accountancy mid-market

    The independent accountancy and advisory business ( formally separate from Evelyn Partners from 31 March 2025) has launched under a new brand – S&W – building on the firm’s heritage but with a clear signal to a new, well invested, client-focused organisation at the forefront of prov...

    Heikki Lanckriet, CEO, 4basebio and	Amy Walker, COO, 4basebio
    2 April 2025

    4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNA

    Cambridge, UK, 02 April 2025 – 4basebio PLC, a company which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, announces that it has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines and He...

    Connectivity, Internet,
    4 April 2025

    Future-proof your School’s internet – Free assessment available

    Is your school’s internet fast, secure, and fully compliant? Reliable connectivity is no longer a luxury – it’s essential. ...

    Connectivity That Bridges Gaps
    8 April 2025

    Case Study - Addenbrooke’s Hospital: Connectivity that bridges gaps

    Addenbrooke’s Hospital, part of the Cambridge University Hospitals NHS Trust on the Cambridge Biomedical Campus, is a healthcare titan serving 20,000 staff, patients, and visitors daily. This bustling hub of medical care and research demands communication that matches its scope. Zinwave...

    Public Safety Solutions
    23 April 2025

    Wilson Connectivity introduces industry-leading public safety solutions to revolutionize emergency response communications

    Wilson Connectivity, a leader in wireless communication technology, announces the launch of its latest public safety solutions, all engineered to ensure reliable communications for first responders during critical emergencies.   ...

    Connectivity Landscape
    17 April 2025

    Wilson Connectivity: Interview with CEO Bruce Lancaster about the wireless communication leader

    Wilson Connectivity is the home of WilsonPro, weBoost, and Zinwave, and it is the market leader in in-building wireless communication technology. Through evolutionary wireless connectivity products and services, Wilson Connectivity pioneers indoor and outdoor cellular amplification tech...

    Catalyser
    31 March 2025

    Applications are open for Catalyser 2025, SBC's free accelerator programme

    Are you a pre-clinical therapeutics start-up? Stevenage Bioscience Catalyst’s Catalyser programme is an accelerator designed to help businesses attract investors and partners, and maximise overall chances of commercial success. ...

    Cyto-Cellect Human IgG Kappa and Viability Assay Kit
    31 March 2025

    Sphere Bio launches Cyto-Cellect Human IgG Kappa and Viability Assay Kit for efficient single-cell selection

    First multiplexed solution introduced with the next-generation Cyto-Mine Chroma platform for more efficient biotherapeutic development Utilizes advanced picodroplet microfluidics technology to integrate analysis of antibody productivity and cell viability of monoclonal antibody pro...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 100
    • Page 101
    • Current page 102
    • Page 103
    • Page 104
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS